# Numyra by Oncora Pharma, LLC: new human prescription drug listing

**Launch Signal Score:** 40/100

| Field | Value |
|---|---|
| Product | Numyra |
| Generic name | Numyra |
| NDC | 85477-312 |
| Labeler | Oncora Pharma, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | UNAPPROVED DRUG OTHER |
| Dosage form | GEL |
| Route | TOPICAL |
| Active ingredients | LIDOCAINE 28 mg/g |
| Pharmacologic class | Amide Local Anesthetic [EPC]; Antiarrhythmic [EPC] |
| Marketing start | 2026-08-23 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.
- Class: Amide Local Anesthetic [EPC]; Antiarrhythmic [EPC].

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=85477-312). Last refreshed: 2026-11-04T18:12:05.743Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.